Cargando…

Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer

BACKGROUND: Circulating tumor DNA (ctDNA) is a promising diagnostic and prognostic marker for many cancers and has been actively investigated in recent years. Previous studies have already demonstrated the potential use of ctDNA methylation markers in the diagnosis and prognostication of colorectal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wu-Hao, Xiao, Jian, Ye, Zi-Yi, Wei, Da-Liang, Zhai, Xiao-Hui, Xu, Rui-Hua, Zeng, Zhao-Lei, Luo, Hui-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713401/ https://www.ncbi.nlm.nih.gov/pubmed/34961566 http://dx.doi.org/10.1186/s13148-021-01216-0

Ejemplares similares

Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
por: Fu, Bo, et al.
Publicado: (2018)

Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Myo–inositol Oxygenase as a Novel Marker in the Diagnosis of Acute Kidney Injury
por: Mertoglu, Cuma, et al.
Publicado: (2018)

Characterization of the promoter region of the bovine SIX1 gene: Roles of MyoD, PAX7, CREB and MyoG
por: Wei, Da-wei, et al.
Publicado: (2017)

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)

Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis
por: Wang, Xin, et al.
Publicado: (2018)

Clinical analysis of the MyoSure hysteroscopic tissue removal system of endometrial polyps in women with an intact hymen
por: Yong, Jiahui, et al.
Publicado: (2021)

The Correlation Between MYO9B Gene Polymorphism and Inflammatory Bowel Disease in the Guangxi Zhuang Population
por: Zeng, Rui-zhi, et al.
Publicado: (2021)

Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis
por: Liu, Yanhe, et al.
Publicado: (2020)

Actin-related protein 5 functions as a novel modulator of MyoD and MyoG in skeletal muscle and in rhabdomyosarcoma
por: Morita, Tsuyoshi, et al.
Publicado: (2022)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Circulating lncRNA UCA1 Promotes Malignancy of Colorectal Cancer via the miR-143/MYO6 Axis
por: Luan, Yunpeng, et al.
Publicado: (2019)

DNA-methylated gene markers for colorectal cancer in TCGA database
por: Zhang, Hui, et al.
Publicado: (2020)

Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children
por: Li, Jun, et al.
Publicado: (2016)

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021)

Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases
por: Wang, De-Shen, et al.
Publicado: (2021)

Circulating Metabolic Markers Related to the Diagnosis of Hepatocellular Carcinoma
por: Xie, Da, et al.
Publicado: (2022)

MYO10 contributes to the malignant phenotypes of colorectal cancer via RACK1 by activating integrin/Src/FAK signaling
por: Ou, Haibin, et al.
Publicado: (2022)

Structural Insights into the Globular Tails of the Human Type V Myosins Myo5a, Myo5b, and Myo5c
por: Velvarska, Hana, et al.
Publicado: (2013)

Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer
por: Lu, Pingxia, et al.
Publicado: (2022)

MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases
por: Wang, Ming-Jie, et al.
Publicado: (2016)

Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
por: Zhang, Xianyu, et al.
Publicado: (2021)

Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients
por: Nicolazzo, Chiara, et al.
Publicado: (2020)

Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma
por: Tian, Xiao-Peng, et al.
Publicado: (2023)

Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
por: Sun, Xiao, et al.
Publicado: (2018)

Detection and Clinical Value of Circulating Tumor Cells as an Assisted Prognostic Marker in Colorectal Cancer Patients
por: Pan, Rui-Jun, et al.
Publicado: (2021)

Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women
por: Montanino Oliva, Mario, et al.
Publicado: (2018)

Association of Clinical Features of Colorectal Cancer with Circulating Tumor Cells and Systemic Inflammatory Markers
por: Xing, Yasi, et al.
Publicado: (2022)

Early Assessment of Colorectal Cancer by Quantifying Circulating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer
por: Chen, Chih-Jung, et al.
Publicado: (2017)

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib
por: Amatu, Alessio, et al.
Publicado: (2019)

Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer
por: XIAO, WENHUA, et al.
Publicado: (2015)

Myo6 gets choosy
por: Tuma, Rbiya S.
Publicado: (2005)

Hæmangiomatous Myo-Fibromata of the Uterus
por: Gupta, N.
Publicado: (1931)

MyoRing treatment of myopia
por: Daxer, Albert
Publicado: (2017)

Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer
por: Wang, Bi, et al.
Publicado: (2017)

MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma
por: Zeng, Ju-deng, et al.
Publicado: (2018)

Role of Phenotypes of Circulating Tumor Cells in the Diagnosis and Treatment of Colorectal Cancer
por: Zhong, Yuchen, et al.
Publicado: (2021)

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

Urinary Chiro- and Myo-Inositol Levels as a Biological Marker for Type 2 Diabetes Mellitus
por: Hong, Jun Hwa, et al.
Publicado: (2012)

Myo1c facilitates G-actin transport to the leading edge of migrating endothelial cells
por: Fan, Yi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ivt90eml59nkrc2gh3md5avtv1